Ion channels and transporters in lymphocyte function and immunity

Nature Reviews Immunology

Volumn 12, Issue 7, 2012, Pages 532-547

  Feske, Stefan ^a   Skolnik, Edward Y ^a,b,c   Prakriya, Murali ^d  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Nephrology   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL; CARRIER PROTEIN; CHLORIDE CHANNEL; CYTOKINE; ION CHANNEL; MAGNESIUM ION; MAGNESIUM TRANSPORTER; POTASSIUM CHANNEL; PURINERGIC P2X RECEPTOR; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; ZINC ION; ZINC TRANSPORTER;

B LYMPHOCYTE; CELL MEMBRANE; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; IMMUNITY; ION TRANSPORT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE MEMBRANE; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SECOND MESSENGER; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CALCIUM SIGNALING; HUMANS; ION CHANNELS; ION TRANSPORT; LYMPHOCYTES; MEMBRANE POTENTIALS; MICE; MODELS, BIOLOGICAL; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES;

EID: 84862861740     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3233     Document Type: Review

References (193)

1. Lewis, R. S. Calcium signaling mechanisms in T lymphocytes. Annu. Rev. Immunol. 19, 497-521 (2001).
2. Parekh, A. B. & Putney, J. W. Store-operated calcium channels. Physiol. Rev. 85, 757-810 (2005).
3. Hoth, M. & Penner, R. Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature 355, 353-356 (1992).
4. + stores. Proc. Natl Acad. Sci. USA 90, 6295-6299 (1993).
5. Prakriya, M. The molecular physiology of CRAC channels. Immunol. Rev. 231, 88-98 (2009).
6. Hogan, P. G., Lewis, R. S. & Rao, A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu. Rev. Immunol. 28, 491-533 (2010).
7. Feske, S., Giltnane, J., Dolmetsch, R., Staudt, L. M. & Rao, A. Gene regulation mediated by calcium signals in T lymphocytes. Nature Immunol. 2, 316-324 (2001).
8. Feske, S. et al. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur. J. Immunol. 26, 2119-2126 (1996).
9. + channel gating in T cells from immunodeficient patients. J. Exp. Med. 202, 651-662 (2005).
10. Le Deist, F. et al. A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood 85, 1053-1062 (1995).
11. Partiseti, M. et al. The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J. Biol. Chem. 269, 32327-32335 (1994).
12. Feske, S. et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441, 179-185 (2006).
13. + entry. Science 312, 1220-1223 (2006).
14. + channel activity. Proc. Natl Acad. Sci. USA 103, 9357-9362 (2006).
15. + channels with distinct functional properties. Curr. Biol. 17, 794-800 (2007).
16. DeHaven, W. I., Smyth, J. T., Boyles, R. R. & Putney, J. W. Calcium inhibition and calcium potentiation of Orai1, Orai2, and Orai3 calcium release-activated calcium channels. J. Biol. Chem. 282, 17548-17556 (2007).
17. Feske, S. Calcium signalling in lymphocyte activation and disease. Nature Rev. Immunol. 7, 690-702 (2007).
18. + influx. Curr. Biol. 15, 1235-1241 (2005).
19. + channel function. J. Cell Biol. 169, 435-445 (2005).
20. + entry. Nature Cell Biol. 11, 669-677 (2009).
21. + store to the plasma membrane. Nature 437, 902-905 (2005).
22. Luik, R. M., Wang, B., Prakriya, M., Wu, M. M. & Lewis, R. S. Oligomerization of STIM1 couples ER calcium depletion to CRAC channel activation. Nature 454, 538-542 (2008).
23. + entry. J. Biol. Chem. 281, 35855-35862 (2006).
24. Stathopulos, P. B., Zheng, L., Li, G. Y., Plevin, M. J. & Ikura, M. Structural and mechanistic insights into STIM1-mediated initiation of store-operated calcium entry. Cell 135, 110-122 (2008).
25. + store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane. J. Cell Biol. 174, 803-813 (2006).
26. + entry: local activation of CRAC channels by STIM1 at ER-plasma membrane junctions. J. Cell Biol. 174, 815-825 (2006).
27. Muik, M. et al. Dynamic coupling of the putative coiled-coil domain of ORAI1 with STIM1 mediates ORAI1 channel activation. J. Biol. Chem. 283, 8014-8022 (2008).
28. Navarro-Borelly, L. et al. STIM1-Orai1 interactions and Orai1 conformational changes revealed by live-cell FRET microscopy. J. Physiol. 586, 5383-5401 (2008).
29. Park, C. Y. et al. STIM1 clusters and activates CRAC channels via direct binding of a cytosolic domain to Orai1. Cell 136, 876-890 (2009).
30. Matsumoto, M. et al. The calcium sensors STIM1 and STIM2 control B cell regulatory function through interleukin-10 production. Immunity 34, 703-714 (2011).
31. Oh-Hora, M. et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nature Immunol. 9, 432-443 (2008).
32. + levels. Cell 131, 1327-1339 (2007).
33. Stathopulos, P. B., Zheng, L. & Ikura, M. Stromal interaction molecule (STIM) 1 and STIM2 calcium sensing regions exhibit distinct unfolding and oligomerization kinetics. J. Biol. Chem. 284, 728-732 (2009).
34. Shaw, P. J. & Feske, S. Physiological and pathophysiological functions of SOCE in the immune system. Front. Biosci. 4, 2253-2268 (2012).
35. Byun, M. et al. Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J. Exp. Med. 207, 2307-2312 (2010).
36. + entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J. Allergy Clin. Immunol. 124, 1311-1318 (2009).
37. Picard, C. et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N. Engl. J. Med. 360, 1971-1980 (2009).
38. Feske, S. CRAC channelopathies. Pflugers Arch. 460, 417-435 (2010).
39. Feske, S. Immunodeficiency due to defects in store-operated calcium entry. Ann. NY Acad. Sci. 1238, 74-90 (2011).
40. + entry in the immune system and beyond. Immunol. Rev. 231, 189-209 (2009).
41. Maul-Pavicic, A. et al. ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis. Proc. Natl Acad. Sci. USA 108, 3324-3329 (2011).
42. Gwack, Y. et al. Hair loss and defective T-and B-cell function in mice lacking ORAI1. Mol. Cell. Biol. 28, 5209-5222 (2008).
43. Beyersdorf, N. et al. STIM1-independent T cell development and effector function in vivo. J. Immunol. 182, 3390-3397 (2009).
44. Feske, S., Picard, C. & Fischer, A. Immunodeficiency due to mutations in ORAI1 and STIM1. Clin. Immunol. 135, 169-182 (2010).
45. + entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection. J. Immunol. 185, 5845-5858 (2010).
46. Ma, J., McCarl, C. A., Khalil, S., Luthy, K. & Feske, S. T-cell-specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of TH1 and TH17 cells. Eur. J. Immunol. 40, 3028-3042 (2010).
47. Schuhmann, M. K. et al. Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation. J. Immunol. 184, 1536-1542 (2010).
48. Stromnes, I. M., Cerretti, L. M., Liggitt, D., Harris, R. A. & Goverman, J. M. Differential regulation of central nervous system autoimmunity by TH1 and TH17 cells. Nature Med. 14, 337-342 (2008).
49. El-behi, M., Rostami, A. & Ciric, B. Current views on the roles of TH1 and TH17 cells in experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 5, 189-197 (2010).
50. Oh-hora, M. Calcium signaling in the development and function of T-lineage cells. Immunol. Rev. 231, 210-224 (2009).
51. Tone, Y. et al. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nature Immunol. 9, 194-202 (2008).
52. Junger, W. G. Immune cell regulation by autocrine purinergic signalling. Nature Rev. Immunol. 11, 201-212 (2011).
53. Woehrle, T. et al. Pannexin-1 hemichannel-mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse. Blood 116, 3475-3484 (2010).
54. Yip, L. et al. Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. FASEB J. 23, 1685-1693 (2009).
55. Baricordi, O. R. et al. An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87, 682-690 (1996).
56. Padeh, S., Cohen, A. & Roifman, C. M. ATP-induced activation of human B lymphocytes via P2-purinoceptors. J. Immunol. 146, 1626-1632 (1991).
57. Adinolfi, E. et al. Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. Mol. Biol. Cell 16, 3260-3272 (2005).
58. Schenk, U. et al. Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels. Sci. Signal. 1, ra6 (2008).
59. Schenk, U. et al. ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci. Signal. 4, ra12 (2011).
60. Ratner, D. & Mueller, C. Immune responses in cystic fibrosis; are they intrinsically defective? Am. J. Respir. Cell Mol. Biol. 8 Mar 2012 (doi:10.1165/rcmb.2011-0399RT).
61. Sharp, A. J. et al. P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J. Neuroinflammation 5, 33 (2008).
62. Mulryan, K. et al. Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors. Nature 403, 86-89 (2000).
63. Solle, M. et al. Altered cytokine production in mice lacking P2X7 receptors. J. Biol. Chem. 276, 125-132 (2001).
64. Yamamoto, K. et al. Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nature Med. 12, 133-137 (2006).
65. Tsien, R. W., Hess, P., McCleskey, E. W. & Rosenberg, R. L. Calcium channels: mechanisms of selectivity, permeation, and block. Annu. Rev. Biophys. Biophys. Chem. 16, 265-290 (1987).
66. Badou, A. et al. Critical role for the β regulatory subunits of Cav channels in T lymphocyte function. Proc. Natl Acad. Sci. USA 103, 15529-15534 (2006).
67. Kotturi, M. F. & Jefferies, W. A. Molecular characterization of L-type calcium channel splice variants expressed in human T lymphocytes. Mol. Immunol. 42, 1461-1474 (2005).
68. + channels in human T cells: pharmacology and molecular characterization of the major α pore-forming and auxiliary β-subunits. J. Biol. Chem. 279, 19566-19573 (2004).
69. + T lymphocytes in the absence of the β3 regulatory subunit of voltage-gated calcium channels. Nature Immunol. 10, 1275-1282 (2009).
70. Omilusik, K. et al. The CaV1.4 calcium channel is a critical regulator of T cell receptor signaling and naive T cell homeostasis. Immunity 35, 349-360 (2011).
71. Cabral, M. D. et al. Knocking down Cav1 calcium channels implicated in TH2 cell activation prevents experimental asthma. Am. J. Respir. Crit. Care Med. 181, 1310-1317 (2010).
72. Park, C. Y., Shcheglovitov, A. & Dolmetsch, R. The CRAC channel activator STIM1 binds and inhibits L-type voltage-gated calcium channels. Science 330, 101-105 (2010).
73. Wang, Y. et al. The calcium store sensor, STIM1, reciprocally controls Orai and CaV1.2 channels. Science 330, 105-109 (2010).
74. + channels. Pflugers Arch. 460, 361-374 (2010).
75. Lewis, R. S. & Cahalan, M. D. Potassium and calcium channels in lymphocytes. Annu. Rev. Immunol. 13, 623-653 (1995).
76. Cahalan, M. D. & Chandy, K. G. The functional network of ion channels in T lymphocytes. Immunol. Rev. 231, 59-87 (2009).
77. Cahalan, M. D., Chandy, K. G., DeCoursey, T. E. & Gupta, S. A voltage-gated potassium channel in human T lymphocytes. J. Physiol. 358, 197-237 (1985).
78. Bezanilla, F. How membrane proteins sense voltage. Nature Rev. Mol. Cell Biol. 9, 323-332 (2008).
79. Xia, X. M. et al. Mechanism of calcium gating in small-conductance calcium-activated potassium channels. Nature 395, 503-507 (1998).
80. Srivastava, S. et al. Phosphatidylinositol-3 phosphatase myotubularin-related protein 6 negatively regulates CD4 T cells. Mol. Cell. Biol. 26, 5595-5602 (2006).
81. + channel KCa3.1. Mol. Cell. Biol. 25, 3630-3638 (2005).
82. + channel KCa3.1. Proc. Natl Acad. Sci. USA 105, 14442-14446 (2008).
83. Cai, X. et al. Tripartite motif containing protein 27 negatively regulates CD4 T cells by ubiquitinating and inhibiting the class II PI3K-C2β. Proc. Natl Acad. Sci. USA 108, 20072-20077 (2011).
84. + channels depolarize human T lymphocytes: mechanism of the antiproliferative effect of charybdotoxin. Proc. Natl Acad. Sci. USA 89, 10094-10098 (1992).
85. Ghanshani, S. et al. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J. Biol. Chem. 275, 37137-37149 (2000).
86. + clearance distinguish TH1 and TH2 lymphocytes. J. Immunol. 164, 1153-1160 (2000).
87. Fanger, C. M. et al. Calcium-activated potassium channels sustain calcium signaling in T lymphocytes. Selective blockers and manipulated channel expression levels. J. Biol. Chem. 276, 12249-12256 (2001).
88. + channel KCa3.1 ameliorates T cell-mediated colitis. Proc. Natl Acad. Sci. USA 107, 1541-1546 (2010).
89. + channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis. Proc. Natl Acad. Sci. USA 98, 13942-13947 (2001).
90. Beeton, C. et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc. Natl Acad. Sci. USA 103, 17414-17419 (2006).
91. Castle, N. A. Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy. Expert Opin. Ther. Pat. 20, 1471-1503 (2010).
92. + channels as targets for specific immunomodulation. Trends Pharmacol. Sci. 25, 280-289 (2004).
93. Baell, J. B. et al. Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity. J. Med. Chem. 47, 2326-2336 (2004).
94. Kalman, K. et al. ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide. J. Biol. Chem. 273, 32697-32707 (1998).
95. Vennekamp, J. et al. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol. Pharmacol. 65, 1364-1374 (2004).
96. + channel, IKCa1: a potential immunosuppressant. Proc. Natl Acad. Sci. USA 97, 8151-8156 (2000).
97. Stocker, J. W. et al. ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice. Blood 101, 2412-2418 (2003).
98. Koni, P. A. et al. Compensatory anion currents in Kv1.3 channel-deficient thymocytes. J. Biol. Chem. 278, 39443-39451 (2003).
99. + channel in effector memory T cells as new target for MS. J. Clin. Invest. 111, 1703-1713 (2003).
100. + T cells-characterization of an effector memory T-cell population in patients with rheumatoid arthritis. Scand. J. Immunol. 60, 199-208 (2004).
101. Friedrich, M. et al. Flow cytometric characterization of lesional T cells in psoriasis: intracellular cytokine and surface antigen expression indicates an activated, memory/effector type 1 immunophenotype. Arch. Dermatol. Res. 292, 519-521 (2000).
102. Gilhar, A., Bergman, R., Assay, B., Ullmann, Y. & Etzioni, A. The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model. J. Invest. Dermatol. 131, 118-124 (2011).
103. Jager, A. & Kuchroo, V. K. Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand. J. Immunol. 72, 173-184 (2010).
104. Sallusto, F. & Lanzavecchia, A. Human TH17 cells in infection and autoimmunity. Microbes Infect. 11, 620-624 (2009).
105. Vennekens, R. & Nilius, B. Insights into TRPM4 function, regulation and physiological role. Handb. Exp. Pharmacol. 179, 269-285 (2007).
106. Launay, P. et al. TRPM4 regulates calcium oscillations after T cell activation. Science 306, 1374-1377 (2004).
107. Weber, K. S., Hildner, K., Murphy, K. M. & Allen, P. M. Trpm4 differentially regulates TH1 and TH2 function by altering calcium signaling and NFAT localization. J. Immunol. 185, 2836-2846 (2010).
108. Vennekens, R. et al. Increased IgE-dependent mast cell activation and anaphylactic responses in mice lacking the calcium-activated nonselective cation channel TRPM4. Nature Immunol. 8, 312-320 (2007).
109. Venkatachalam, K. & Montell, C. TRP channels. Annu. Rev. Biochem. 76, 387-417 (2007).
110. Wenning, A. S. et al. TRP expression pattern and the functional importance of TRPC3 in primary human T-cells. Biochim. Biophys. Acta 1813, 412-423 (2011).
111. Ramsey, I. S., Delling, M. & Clapham, D. E. An introduction to TRP channels. Annu. Rev. Physiol. 68, 619-647 (2006).
112. Owsianik, G., Talavera, K., Voets, T. & Nilius, B. Permeation and selectivity of TRP channels. Annu. Rev. Physiol. 68, 685-717 (2006).
113. Nilius, B., Mahieu, F., Karashima, Y. & Voets, T. Regulation of TRP channels: a voltage-lipid connection. Biochem. Soc. Trans. 35, 105-108 (2007).
114. Wang, J. et al. Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J. Immunol. 182, 4036-4045 (2009).
115. DeHaven, W. I. et al. TRPC channels function independently of STIM1 and Orai1. J. Physiol. 587, 2275-2298 (2009).
116. Sumoza-Toledo, A. & Penner, R. TRPM2: a multifunctional ion channel for calcium signalling. J. Physiol. 589, 1515-1525 (2011).
117. Yamamoto, S., Takahashi, N. & Mori, Y. Chemical physiology of oxidative stress-activated TRPM2 and TRPC5 channels. Prog. Biophys. Mol. Biol. 103, 18-27 (2010).
118. Beck, A., Kolisek, M., Bagley, L. A., Fleig, A. & Penner, R. Nicotinic acid adenine dinucleotide phosphate and cyclic ADP-ribose regulate TRPM2 channels in T lymphocytes. FASEB J. 20, 962-964 (2006).
119. Guse, A. H. et al. Regulation of calcium signalling in T lymphocytes by the second messenger cyclic ADP-ribose. Nature 398, 70-73 (1999).
120. Di, A. et al. The redox-sensitive cation channel TRPM2 modulates phagocyte ROS production and inflammation. Nature Immunol. 13, 29-34 (2012).
121. +-permeable channel activated by changes in redox status confers susceptibility to cell death. Mol. Cell 9, 163-173 (2002).
122. + influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nature Med. 14, 738-747 (2008).
123. Scarpa, A. & Brinley, F. J. In situ measurements of free cytosolic magnesium ions. Fed. Proc. 40, 2646-2652 (1981).
124. Modiano, J. F., Kelepouris, E., Kern, J. A. & Nowell, P. C. Requirement for extracellular calcium or magnesium in mitogen-induced activation of human peripheral blood lymphocytes. J. Cell. Physiol. 135, 451-458 (1988).
125. Abboud, C. N., Scully, S. P., Lichtman, A. H., Brennan, J. K. & Segel, G. B. The requirements for ionized calcium and magnesium in lymphocyte proliferation. J. Cell. Physiol. 122, 64-72 (1985).
126. + revealed by human T-cell immunodeficiency. Nature 475, 471-476 (2011).
127. + homeostasis. Science 322, 756-760 (2008).
128. + inhibited channel and kinase. Adv. Exp. Med. Biol. 704, 173-183 (2011).
129. + homeostasis in mammals. Nature Commun. 1, 109 (2010).
130. Schlingmann, K. P. et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nature Genet. 31, 166-170 (2002).
131. Walder, R. Y. et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nature Genet. 31, 171-174 (2002).
132. + homeostasis by TRPM7. Cell 114, 191-200 (2003).
133. Bae, C. Y. & Sun, H. S. TRPM7 in cerebral ischemia and potential target for drug development in stroke. Acta Pharmacol. Sin. 32, 725-733 (2011).
134. + transporter with channel-like properties. BMC Genomics 6, 48 (2005).
135. Zhou, H. & Clapham, D. E. Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development. Proc. Natl Acad. Sci. USA 106, 15750-15755 (2009).
136. Haase, H. & Rink, L. Functional significance of zinc-related signaling pathways in immune cells. Annu. Rev. Nutr. 29, 133-152 (2009).
137. Hirano, T. et al. Roles of zinc and zinc signaling in immunity: zinc as an intracellular signaling molecule. Adv. Immunol. 97, 149-176 (2008).
138. Honscheid, A., Rink, L. & Haase, H. T-lymphocytes: a target for stimulatory and inhibitory effects of zinc ions. Endocr. Metab. Immune Disord. Drug Targets 9, 132-144 (2009).
139. Haase, H., Hebel, S., Engelhardt, G. & Rink, L. Flow cytometric measurement of labile zinc in peripheral blood mononuclear cells. Anal. Biochem. 352, 222-230 (2006).
140. Rukgauer, M., Klein, J. & Kruse-Jarres, J. D. Reference values for the trace elements copper, manganese, selenium, and zinc in the serum/plasma of children, adolescents, and adults. J. Trace Elem. Med. Biol. 11, 92-98 (1997).
141. Kaltenberg, J. et al. Zinc signals promote IL-2-dependent proliferation of T cells. Eur. J. Immunol. 40, 1496-1503 (2010).
142. Aydemir, T. B., Liuzzi, J. P., McClellan, S. & Cousins, R. J. Zinc transporter ZIP8 (SLC39A8) and zinc influence IFN-γ expression in activated human T cells. J. Leukoc. Biol. 86, 337-348 (2009).
143. Yu, M. et al. Regulation of T cell receptor signaling by activation-induced zinc influx. J. Exp. Med. 208, 775-785 (2011).
144. Kury, S. et al. Identification of SLC39A4, a gene involved in acrodermatitis enteropathica. Nature Genet. 31, 239-240 (2002).
145. Wang, K., Zhou, B., Kuo, Y. M., Zemansky, J. & Gitschier, J. A novel member of a zinc transporter family is defective in acrodermatitis enteropathica. Am. J. Hum. Genet. 71, 66-73 (2002).
146. Ackland, M. L. & Michalczyk, A. Zinc deficiency and its inherited disorders-a review. Genes Nutr. 1, 41-49 (2006).
147. Fraker, P. J. & King, L. E. Reprogramming of the immune system during zinc deficiency. Annu. Rev. Nutr. 24, 277-298 (2004).
148. + in vitro. Exp. Cell Res. 61, 229-230 (1970).
149. Fraker, P. J., Jardieu, P. & Cook, J. Zinc deficiency and immune function. Arch. Dermatol. 123, 1699-1701 (1987).
150. Wellinghausen, N., Martin, M. & Rink, L. Zinc inhibits interleukin-1-dependent T cell stimulation. Eur. J. Immunol. 27, 2529-2535 (1997).
151. Tanaka, S., Akaishi, E., Hosaka, K., Okamura, S. & Kubohara, Y. Zinc ions suppress mitogen-activated interleukin-2 production in Jurkat cells. Biochem. Biophys. Res. Commun. 335, 162-167 (2005).
152. Kim, P. W., Sun, Z. Y., Blacklow, S. C., Wagner, G. & Eck, M. J. A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8. Science 301, 1725-1728 (2003).
153. Huang, J. et al. An approach to assay calcineurin activity and the inhibitory effect of zinc ion. Anal. Biochem. 375, 385-387 (2008).
154. Takahashi, K. et al. Zinc inhibits calcineurin activity in vitro by competing with nickel. Biochem. Biophys. Res. Commun. 307, 64-68 (2003).
155. Lichten, L. A. & Cousins, R. J. Mammalian zinc transporters: nutritional and physiologic regulation. Annu. Rev. Nutr. 29, 153-176 (2009).
156. Dufner-Beattie, J., Huang, Z. L., Geiser, J., Xu, W. & Andrews, G. K. Generation and characterization of mice lacking the zinc uptake transporter ZIP3. Mol. Cell. Biol. 25, 5607-5615 (2005).
157. Overbeck, S., Uciechowski, P., Ackland, M. L., Ford, D. & Rink, L. Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9. J. Leukoc. Biol. 83, 368-380 (2008).
158. Nishida, K. et al. Zinc transporter Znt5/Slc30a5 is required for the mast cell-mediated delayed-type allergic reaction but not the immediate-type reaction. J. Exp. Med. 206, 1351-1364 (2009).
159. Cahalan, M. D. & Lewis, R. S. Role of potassium and chloride channels in volume regulation by T lymphocytes. Soc. Gen. Physiol. Ser. 43, 281-301 (1988).
160. Lewis, R. S., Ross, P. E. & Cahalan, M. D. Chloride channels activated by osmotic stress in T lymphocytes. J. Gen. Physiol. 101, 801-826 (1993).
161. Lepple-Wienhues, A. et al. The tyrosine kinase p56lck mediates activation of swelling-induced chloride channels in lymphocytes. J. Cell Biol. 141, 281-286 (1998).
162. Szabo, I. et al. Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes. Proc. Natl Acad. Sci. USA 95, 6169-6174 (1998).
163. Tian, J. et al. γ-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J. Immunol. 173, 5298-5304 (2004).
164. + T cells in BB rats developing diabetes compared to their congenic littermates. Mol. Immunol. 48, 399-407 (2011).
165. Carter, C. R., Kozuska, J. L. & Dunn, S. M. Insights into the structure and pharmacology of GABAA receptors. Future Med. Chem. 2, 859-875 (2010).
166. Bhat, R. et al. Inhibitory role for GABA in autoimmune inflammation. Proc. Natl Acad. Sci. USA 107, 2580-2585 (2010).
167. Bjurstom, H. et al. GABA, a natural immunomodulator of T lymphocytes. J. Neuroimmunol. 205, 44-50 (2008).
168. Tian, J., Chau, C., Hales, T. G. & Kaufman, D. L. GABAA receptors mediate inhibition of T cell responses. J. Neuroimmunol. 96, 21-28 (1999).
169. Bergeret, M. et al. GABA modulates cytotoxicity of immunocompetent cells expressing GABAA receptor subunits. Biomed. Pharmacother. 52, 214-219 (1998).
170. Tian, J., Yong, J., Dang, H. & Kaufman, D. L. Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis. Autoimmunity 44, 465-470 (2011).
171. + T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR). Clin. Exp. Immunol. 106, 374-388 (1996).
172. Chen, J. H., Schulman, H. & Gardner, P. A cAMP-regulated chloride channel in lymphocytes that is affected in cystic fibrosis. Science 243, 657-660 (1989).
173. + lymphocytes leads to aberrant cytokine secretion and hyperinflammatory adaptive immune responses. Am. J. Respir. Cell Mol. Biol. 44, 922-929 (2011).
174. Camerino, D. C., Tricarico, D. & Desaphy, J. F. Ion channel pharmacology. Neurotherapeutics 4, 184-198 (2007).
175. Naylor, J., Milligan, C. J., Zeng, F., Jones, C. & Beech, D. J. Production of a specific extracellular inhibitor of TRPM3 channels. Br. J. Pharmacol. 155, 567-573 (2008).
176. Xu, S. Z. et al. Generation of functional ion-channel tools by E3 targeting. Nature Biotechnol. 23, 1289-1293 (2005).
177. Chandy, K. G., DeCoursey, T. E., Cahalan, M. D., McLaughlin, C. & Gupta, S. Voltage-gated potassium channels are required for human T lymphocyte activation. J. Exp. Med. 160, 369-385 (1984).
178. McNally, B. A., Yamashita, M., Engh, A. & Prakriya, M. Structural determinants of ion permeation in CRAC channels. Proc. Natl Acad. Sci. USA 106, 22516-22521 (2009).
179. Zhou, Y., Ramachandran, S., Oh-Hora, M., Rao, A. & Hogan, P. G. Pore architecture of the ORAI1 store-operated calcium channel. Proc. Natl Acad. Sci. USA 107, 4896-4901 (2010).
180. Prakriya, M. et al. Orai1 is an essential pore subunit of the CRAC channel. Nature 443, 230-233 (2006).
181. Vig, M. et al. CRACM1 multimers form the ion-selective pore of the CRAC channel. Curr. Biol. 16, 2073-2079 (2006).
182. +-dependent inactivation of CRAC channels: evidence for coupling of permeation and gating. J. Gen. Physiol. 130, 525-540 (2007).
183. Yeromin, A. V. et al. Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature 443, 226-229 (2006).
184. Kawasaki, T., Lange, I. & Feske, S. A minimal regulatory domain in the C terminus of STIM1 binds to and activates ORAI1 CRAC channels. Biochem. Biophys. Res. Commun. 385, 49-54 (2009).
185. +-dependent inactivation of CRAC channels. Proc. Natl Acad. Sci. USA 106, 15495-15500 (2009).
186. Muik, M. et al. A cytosolic homomerization and a modulatory domain within STIM1 C terminus determine coupling to ORAI1 channels. J. Biol. Chem. 284, 8421-8426 (2009).
187. Yuan, J. P. et al. SOAR and the polybasic STIM1 domains gate and regulate Orai channels. Nature Cell Biol. 11, 337-343 (2009).
188. Tschopp, J. & Schroder, K. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nature Rev. Immunol. 10, 210-215 (2010).
189. Liuzzi, J. P. & Cousins, R. J. Mammalian zinc transporters. Annu. Rev. Nutr. 24, 151-172 (2004).
190. Baughman, J. M. et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature 476, 341-345 (2011).
191. De Stefani, D. et al. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature 476, 336-340 (2011).
192. Romani, A. M. & Scarpa, A. Regulation of cellular magnesium. Front. Biosci. 5, D720-D734 (2000).
193. Desai, B. et al. Cleavage of TRPM7 releases the kinase domain from the ion channel and regulates its participation in Fas-induced apoptosis. Dev. Cell (in the press).